Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation PotentialNews DeskFebruary 26, 20260 The biopharmaceutical industry is making a big push toward oral autoimmune disease drugs that offer similar efficacy but more dosing…